The dose of 131I received by cells expressing NIS is determined by the levels of NIS expressed, the dose of the radioisotope, and the effective half-life of the isotope in the tumor, which is determined by the physical half-life (8.021 days for 131I) and biological half-life of the isotope. This evidence concerns the gene SLC5A5 and neoplasm.